Ladenburg Thalmann Financial Services’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$2K Hold
100
﹤0.01% 5138
2019
Q3
$1K Buy
+100
New +$1.19K ﹤0.01% 5208
2018
Q4
Sell
-100
Closed -$2K 5414
2018
Q3
$2K Sell
100
-100
-50% -$2.3K ﹤0.01% 4929
2018
Q2
$4K Hold
200
﹤0.01% 4707
2018
Q1
$4K Hold
200
﹤0.01% 4707
2017
Q4
$5K Buy
+200
New +$4.9K ﹤0.01% 4551
2017
Q3
Sell
-2,500
Closed -$51K 5073
2017
Q2
$51K Buy
2,500
+1,500
+150% +$31.2K ﹤0.01% 3016
2017
Q1
$27K Buy
+1,000
New +$20.4K ﹤0.01% 3361

Other funds holding FLXN

Ladenburg Thalmann Financial Services's FLXN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Flexion Therapeutics, Inc. (FLXN) position steady in Q4 2019 at 100 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5138.

Ladenburg Thalmann Financial Services first reported a position in FLXN in Q1 2017 and has held it in 8 quarters since. The position peaked at $51K in Q2 2017. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 100 shares of Flexion Therapeutics, Inc. worth $2K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Flexion Therapeutics, Inc. share count unchanged in Q4 2019.
  • Flexion Therapeutics, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5138 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and has held it in 8 quarters since.
  • Ladenburg Thalmann Financial Services's Flexion Therapeutics, Inc. position peaked at $51K in Q2 2017.
  • 133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.